Section Arrow
IRMD.NASDAQ
- iRadimed Corp
Quotes are at least 15-min delayed:2026/01/25 05:38 EST
Regular Hours
Last
 100.86
-3.03 (-2.92%)
Day High 
104.01 
Prev. Close
103.89 
1-M High
104.93 
Volume 
58.58K 
Bid
96.43
Ask
160.96
Day Low
99.57 
Open
104.01 
1-M Low
94.54 
Market Cap 
1.32B 
Currency 美元 
P/E 62.96 
%Yield 1.17 
10-SMA 101.23 
20-SMA 99.32 
50-SMA 94.88 
52-W High 100.387 
52-W Low 47.4775 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.65/2.11
Enterprise Value
1.32B
Balance Sheet
Book Value Per Share
7.73
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
73.24M
Operating Revenue Per Share
4.95
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MOVEMovano Inc16.74+9.77+140.17%-- 
ABTAbbott Laboratories107.42-1.19-1.10%13.69PE
BSXBoston Scientific Corp92.51+1.22+1.34%48.82PE
MDTMedtronic plc100.88-0.46-0.45%27.46PE
PFSAProfusa Inc0.114-0.0014-1.21%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.